Europe

Medical marijuana demand, imports continue to climb in Germany

While Germany is on track to become one of the largest federally legal medical marijuana markets in the world, a lack of publicly available data on consumption makes it difficult for companies to assess the actual market opportunities. Unlike Health Canada, German authorities don’t publish centralized statistical information of the number of patients or amount […]

Read More

UK to rely on imports to meet ‘unlicensed’ medical cannabis demand

The United Kingdom likely will lean on imports to supply “unlicensed” cannabis-derived products after medical marijuana becomes available by prescription later this year. A new report by a council studying medical cannabis in the U.K. advises the government should encourage pharmaceutical companies to apply to the Healthcare Products Regulatory Agency for a license to market cannabis-derived medicinal […]

Read More

Pharma giant Bayer on cannabis: No decision ‘until we fully understand market’

Monsanto pulled its Health Canada-approved pesticide from the cannabis market months ahead of a planned merger with German company Bayer, but the pharmaceutical giant is not ruling out an eventual entry into the sector. Health Canada told Marijuana Business Daily that Monsanto – the manufacturer of Actinovate SP – requested cannabis be removed from the […]

Read More

France launches committee to evaluate medical cannabis market

A French health agency has launched a temporary scientific committee to assess how to create a medical cannabis market in France. The nation legalized cannabis-based medicines in 2013, but no product is legally available because the market has not been developed. The French National Agency for the Safety of Medicines and Health Products (ANSM) has […]

Read More

Germany won’t award first cannabis cultivation licenses until early 2019

Germany intends to award the country’s first domestic licenses for medical cannabis cultivation in the first quarter of next year, with the first crop expected in 2020. The government laid out the timetable in a written response to queries from the Free Democratic Party parliamentary group in the Bundestag, according to the weekly German-language medical magazine […]

Read More

‘Global paradigm shift’: International cannabis business opportunities will accelerate

Hours after Constellation Brands announced its marijuana-industry-record investment of 5 billion Canadian  dollars ($3.8 billion) in Canada’s Canopy Growth, experts told cannabis entrepreneurs and investors at MJBizConINT’L in Toronto on Wednesday that global cannabis business opportunities will rapidly accelerate. The move by Constellation – which owns, distributes and markets 100 beer, wine and spirits brands, including Corona and Robert […]

Read More

Multibillion-dollar marijuana industry takes the stage at MJBizConINT’L

There is no end in sight to business opportunities in the multibillion-dollar international cannabis industry, experts said Tuesday as the inaugural MJBizConINT’L kicked off in Toronto. More than 2,000 marijuana entrepreneurs and investors from 31 countries are gathering for the three-day, international-focused conference to explore strategies that include: Tapping into international investment capital. Building a global cannabis […]

Read More

Italy looks to expand medical marijuana sales to all pharmacies, increase production

Italy signaled its intention to loosen the military’s grip on the cultivation of medical marijuana, significantly ramp up production and make MMJ “available in all pharmacies” across the country. The move also could increase opportunities for international MMJ companies participating in the nation’s medical cannabis industry. Italian Health Minister Giulia Grillo made the announcement in […]

Read More